⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12950636 | 0.85 | — | — | |
| SCHEMBL21561701 | 0.85 | — | — | |
| SCHEMBL22317545 | 0.80 | — | — | |
| SCHEMBL14537229 | 0.80 | — | — | |
| SCHEMBL14295971 | 0.80 | — | — | |
| SCHEMBL21202665 | 0.76 | — | — | |
| SCHEMBL21202667 | 0.76 | — | — | |
| SCHEMBL15964501 | 0.76 | — | — | |
| SCHEMBL1643468 | 0.76 | — | — | |
| SCHEMBL19608815 | 0.76 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11739332-B2 | Antisense oligomers targeting PCSK9 | ROCHE INNOVATION CENTER COPENHAGEN A/S (DK) | 2023-08-29 | — | — | US | disclosed |
| US-20220025376-A1 | ANTISENSE OLIGOMERS TARGETING PCSK9 | ROCHE INNOVATION CENTER COPENHAGEN A/S (DK) | 2022-01-27 | — | — | US | disclosed |